Format

Send to

Choose Destination
BMC Infect Dis. 2015 Dec 9;15:559. doi: 10.1186/s12879-015-1297-x.

Rapid dissemination of colistin and carbapenem resistant Acinetobacter baumannii in Central Greece: mechanisms of resistance, molecular identification and epidemiological data.

Author information

1
Department of Microbiology, University Hospital of Larissa, Larissa, Greece.
2
Faculty of Medicine and University Hospital in Plzen, Charles University in Prague, Plzen, Czech Republic.
3
Department of Medicine, Medical School, University of Thessaly, Larissa, Greece.
4
Department of Critical Care, Medical School, University of Thessaly, Larissa, Greece.
5
Department of Microbiology, University Hospital of Larissa, Larissa, Greece. petinaki@med.uth.gr.
6
Department of Microbiology, Medical School, University of Thessaly, Larissa, Greece. petinaki@med.uth.gr.

Abstract

BACKGROUND:

Colistin-resistant/carbapenem-resistant Acinetobacter baumannii is a significant challenge for antibiotic treatment and infection control policies. Since 2012, in Central Greece an increase of colistin/pan- resistant A. baumannii has occurred, indicating the need for further analysis.

METHODS:

A total of 86 colistin-resistant/carbapenem-resistant out of 1228 A. baumannii clinical isolates, consecutively collected between 2012 and 2014 in a tertiary Greek hospital of Central Greece, as well as one environmental isolate from surveillance cultures were studied. Molecular typing and mechanisms of resistance to colistin and to carbapenems were assessed, whereas, epidemiological and clinical data of the patients were reviewed.

RESULTS:

During the study period, the rate of colistin resistance gradually increased and reached 21.1 % in 2014. All colistin-resistant/carbapenem-resistant A. baumannii belonged to 3LST ST101 clone that corresponds to the international clonal lineage II. Carbapenem resistance was associated with the presence of bla oxa-23-like, while resistance to colistin probably correlated with G54E and R109H amino acid substitutions in PmrA and PmrC, respectively.

CONCLUSIONS:

Epidemiological data of the patients indicated that the first detection of colistin-resistant/carbapenem-resistant ST101 clone in the University Hospital of Larissa (UHL) was associated with a patient who previously had received colistin, while, the movement of the infected patients into the hospital probably resulted to its spread.

PMID:
26653099
PMCID:
PMC4675053
DOI:
10.1186/s12879-015-1297-x
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center